Vienna, May 26, 2021/ PRNewswire/– Lexogen, company of RNA Experts, is honored to announce that it has earned ISO 9001:2015 certification from TÜV Austria CERT GmbH for its quality management
Vienna, Austria, November 12, 2020 /PRNewswire/ – Lexogen GmbH, a Vienna-based market leader in Next-Generation Sequencing (NGS) and transcriptomics announced today the launch of a pioneering ultra-high-throughput SARS-CoV-2 test that
Explore Further by Detecting Twice as Many Genes per Cell Vienna, October 22, 2020 /PRNewswire/ – Lexogen, a transcriptomics and Next-Generation Sequencing company today announced the introduction of the LUTHOR
Vienna, Austria, August 19, 2020 – Today Lexogen, the transcriptomics and next-generation sequencing company, announced the launch of the QuantSeq-Pool Sample-Barcoded 3’ mRNA-Seq Library Prep Kit. The QuantSeq-Pool method combines
Vienna, Austria, August 4, 2020 – Today Lexogen, the transcriptomics and next-generation sequencing company, announced that Stéphane Barges, PhD, MBA has been appointed as new Chief Executive Officer effective from
Vienna, Austria, and San Diego, CA, USA, June 17, 2020 – Lexogen, a transcriptomics and Next Generation Sequencing company, and OnRamp Bioinformatics, a provider of cloud-based genomic analysis and collaboration tools,
Vienna, Austria, June 4, 2020 – Today Lexogen, the transcriptomics and next-generation sequencing company, launched the new TraPR Small RNA Isolation Kit. TraPR (Trans-Kingdom, Rapid, Affordable Purification of RISCs) is
Vienna, Austria, April 29, 2020 – Lexogen GmbH, a Vienna based Next-Generation Sequencing (NGS) and transcriptomics company, receives funding from the Austria Research Promotion Agency (FFG) for the development of
VIENNA, AUSTRIA, MARCH 24, 2020 – Lexogen is pleased to announce the appointment of Intra Globus Biosystems Pvt. Ltd (IGB) as its official distributor in India, as a further step
RNA extracted from bacterial species comprises up to 98 % of ribosomal RNAs (rRNA), preventing the in-depth analysis of RNAs of interest, particularly in the context of Next Generation Sequencing
Lexogen GmbH
Campus Vienna Biocenter 5
1030 Vienna, Austria
Telephone:
+43 (0) 1 345 1212
Sales support:
+43 (0) 1 345 1212-42
Technical support:
+43 (0) 1 345 1212-41
Working hours: 9:00 – 17:00 (CET)
Fax: +43 (0) 1 345 1212-99
Email: info@lexogen.com
Company number: FN 297318 h
VAT number: ATU63622048
Lexogen, Inc.
51 Autumn Pond Park
Greenland, NH 03840, US
Telephone:
+1-603-431-4300 ext.0
+1-877-Lexogen
(+1-877-539-6436) ext. 0
Sales inquiries:
Northeast: +1-312-978-6413
Southeast: +1-615-968-3325
Northwest: +1-415-726-4318
Southwest: +1-520-934-0678
Technical support:
+1-949-767-1631
(Working hours: 9:00 – 17:00 (EST))
+1-603-498-1666
(Working hours: 7:30 – 15:30 (CST))
Fax: +1-603-431-4333
Lexogen Newsletter
Subscribe to our mailing list to be among the first to get updates from us!
Copyright © 2026 Lexogen GmbH. All rights reserved | Impressum | Privacy Policy | Terms and Conditions | Whistleblowing
Product Short Description
PRICE
Product Short Description
PRICE
Product Short Description
PRICE
